14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 4.010 17 days ( 7.77 % )
Last Price $8.01 0.125 %
High/ Low $7.91 - $8.49 11.88%
Chg 7 Days 0.88 % $7.94 $8.01
Chg 30 Days 136.98 % $3.38 $8.01
Chg 12 mos 224.29 % $2.47 $8.01
Trend - 3 mos 71.92 % Width: 210.60 %
Trend - 12 mos 73.91 % Width: 308.61 %
Pred. range - 3 mos $6.83 - $21.21 -14.76 % - 164.74 %
Pred. range - 12 mos $4.79 - $19.55 -40.26 % - 144.11 %
Short MA avg 3 mos Buy Jun 24, 2024 - 2 days
Long MA avg 3 mos Buy May 29, 2024 - 19 days
Short/Long MA avg 3 mos Buy May 29, 2024 - 19 days
Short MA avg 12 mos Buy May 29, 2024 - 19 days
Long MA avg 12 mos Buy May 29, 2024 - 19 days
Short/Long MA avg 12 mos Buy Nov 16, 2023 - 151 days
Pivot Short Sell May 28, 2024 - 20 days
Bollinger Buy Dec 04, 2023 - 140 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Summit Therapeutics plc

Summit Therapeutics plc Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, fo... SMMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT